Unity Biotechnology, Inc. announced that On April 10, 2023, the company and Jamie Dananberg agreed that Dr. Dananberg would be leaving his employment with the Company as Chief Medical Officer on April 30, 2023.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.53 USD | -4.38% | -4.97% | -20.73% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-20.73% | 25.68M | |
+3.91% | 109B | |
+10.87% | 105B | |
+1.28% | 22.25B | |
-13.14% | 22.09B | |
-7.05% | 18.68B | |
-38.36% | 17.58B | |
-10.66% | 16.85B | |
+3.75% | 13.76B | |
+36.70% | 12.46B |
- Stock Market
- Equities
- UBX Stock
- News Unity Biotechnology, Inc.
- Unity Biotechnology, Inc. Announces Resignation of Jamie Dananberg as Chief Medical Officer, Effective April 30, 2023